Most cancers sufferers don’t simply combat the illness – they combat the system. As we speak, life-saving therapies are routinely delayed by days and even weeks attributable to handbook, error-prone workflows. To resolve this, RISA Labs has raised a $3.5M funding spherical to assist healthcare organizations remove some of the persistent boundaries to well timed most cancers care: prior authorization delays. RISA Labs has already confirmed that quicker care is feasible by dramatically decreasing handbook workflows and administrative burden.
The seed was led by Binny Bansal (Flipkart co-founder) with participation from Oncology Ventures, Common Catalyst, z21 Ventures, ODD BIRD VC, and Ashish Gupta. The capital will speed up deployments within the subsequent 100 most cancers facilities throughout the nation inside the subsequent two years.
Additionally Learn: How AI may also help Companies Run Service Centres and Contact Centres at Decrease Prices?
RISA founders: Kumar Shivang and Kshitij Jaggi.
“Prior authorizations stay one of many least automated components of our healthcare system,” stated Ben Freeberg, Managing Companion at Oncology Ventures. “In oncology, the stakes are larger. 70% of most cancers sufferers expertise delays in care due to prior authorization necessities. In 33% of these circumstances, the delay is one month—a time window that may improve the danger of loss of life by 13% in sure most cancers sorts. The present system isn’t simply inefficient – it’s harmful.”
RISA’s platform—Enterprise Working System as a Service (BOSS) – just isn’t one other automation bot or AI assistant. It’s a full-stack orchestration engine constructed for the vertical complexity of healthcare, As an alternative of counting on people to push paperwork or brittle bots that break when programs change, BOSS decomposes advanced workflows into micro-tasks, then delegates them to a community of clever brokers—LLMs, digital twins, and reinforcement learners, extending throughout an establishment’s total software program stack. This permits BOSS to create a parallel digital workforce, working on behalf of groups and alongside them. A 1,000-person establishment can perform like a 2,000-person one in a single day, with digital brokers making up half the workforce.
“We’ve had Home windows, we’ve had Linux, we’ve had Mac, every OS helped people extract extra from machines. However now, we’re drowning in software program. There’s an excessive amount of of it, and a scarcity of expert labor to function it. Software program that was alleged to get work carried out has change into work itself,” Kshitij Jaggi, co-founder and CEO of RISA Labs provides. “BOSS is an AI OS designed for the post-ChatGPT period : the place work is not about studying instruments, however merely expressing intent.”
At a number one US most cancers heart, BOSS decreased prior authorization occasions from half-hour to underneath 5. In just some months, it processed over $1 million in drugs, freed up 80 % of workers time, and reduce administrative prices by 66 %.
“Most cancers care is time delicate. Each delay in therapy can have an effect on outcomes. Prior authorizations proceed to sluggish us down. What RISA is constructing isn’t just good expertise. It removes boundaries so our groups can transfer quicker and keep centered on what issues most: caring for sufferers,” stated Dr. Jeffrey Vacirca, CEO of New York Most cancers and Blood Specialists.
Primarily based in Silicon Valley, RISA is based by IIT Kanpur alumni and repeat founders, Kshitij Jaggi (CEO) and Kumar Shivang (CTO) who’ve been associates for greater than a decade now, who’ve beforehand constructed and scaled City Well being. Their frustration with fragmented, sluggish, and error-prone healthcare workflows throughout that journey impressed the duo to take a systems-first strategy, main them to develop a foundational AI working system that may simulate, perceive, and orchestrate total institutional workflows from finish to finish.
“BOSS is low-entropy system design to carry move state in system-2 pondering for LLMs; it goals to maximise AI brokers’ usefulness for important issues like oncology operations,” stated Kumar Shivang, co-founder & CTO of RISA. “Its orchestration layer then turns that intelligence into exact, real-time execution with integrations with programs of document like Flatiron Well being’s EMR.”
Newest Information: LambdaTest Launches HyperExecute MCP Server to Automate Testing Setups with AI
RISA’s founding group first explored these ideas by analysis, co-authoring ‘Digital Twin Ecosystem in Oncology Medical Operations’—an early effort to check smarter, AI-driven most cancers care workflows. This foundational work laid the conceptual groundwork that later translated into tangible enhancements in real-world oncology operations.
RISA’s platform indicators a broader shift in enterprise AI. “As AI brokers unbundle the $4.6 trillion providers trade, RISA’s BOSS leads the best way—confirmed in oncology and constructed to scale,” stated Binny Bansal, co-founder of Flipkart and lead investor.”
Wanting forward, RISA plans to increase throughout a number of nodes inside the oncology ecosystem, positioning itself because the AI transformation associate for each operational and scientific workflows. This contains enabling coordination and intelligence throughout suppliers, life sciences organizations, and different stakeholders all through the journey of a drug – extending the corporate’s long run imaginative and prescient to constructing a unified layer for AI-driven orchestration in oncology.
[To share your insights with us as part of editorial or sponsored content, please write to psen@itechseries.com]
